These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26565800)

  • 21. Type II heat-labile enterotoxins from 50 diverse Escherichia coli isolates belong almost exclusively to the LT-IIc family and may be prophage encoded.
    Jobling MG; Holmes RK
    PLoS One; 2012; 7(1):e29898. PubMed ID: 22242186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinctive immunomodulatory and inflammatory properties of the Escherichia coli type II heat-labile enterotoxin LT-IIa and its B pentamer following intradermal administration.
    Mathias-Santos C; Rodrigues JF; Sbrogio-Almeida ME; Connell TD; Ferreira LC
    Clin Vaccine Immunol; 2011 Aug; 18(8):1243-51. PubMed ID: 21677110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Adjuvant Effects of Type II Heat-Labile Enterotoxins in Combination with Two Different Candidate Ricin Toxin Vaccine Antigens.
    Vance DJ; Greene CJ; Rong Y; Mandell LM; Connell TD; Mantis NJ
    Clin Vaccine Immunol; 2015 Dec; 22(12):1285-93. PubMed ID: 26491037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structure of a new heat-labile enterotoxin, LT-IIb.
    van den Akker F; Sarfaty S; Twiddy EM; Connell TD; Holmes RK; Hol WG
    Structure; 1996 Jun; 4(6):665-78. PubMed ID: 8805549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LT-IIb(T13I), a non-toxic type II heat-labile enterotoxin, augments the capacity of a ricin toxin subunit vaccine to evoke neutralizing antibodies and protective immunity.
    Greene CJ; Chadwick CM; Mandell LM; Hu JC; O'Hara JM; Brey RN; Mantis NJ; Connell TD
    PLoS One; 2013; 8(8):e69678. PubMed ID: 23936344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional diversity of heat-labile toxins (LT) produced by enterotoxigenic Escherichia coli: differential enzymatic and immunological activities of LT1 (hLT) AND LT4 (pLT).
    Rodrigues JF; Mathias-Santos C; Sbrogio-Almeida ME; Amorim JH; Cabrera-Crespo J; Balan A; Ferreira LC
    J Biol Chem; 2011 Feb; 286(7):5222-33. PubMed ID: 21135101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit.
    de Haan L; Verweij WR; Feil IK; Holtrop M; Hol WG; Agsteribbe E; Wilschut J
    Immunology; 1998 Jul; 94(3):424-30. PubMed ID: 9767427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of humoral immunity by the type II heat-labile enterotoxin LT-IIb is dependent upon IL-6 and neutrophils.
    Greene CJ; Hu JC; Vance DJ; Rong Y; Mandell L; King-Lyons N; Masso-Welch P; Mantis NJ; Connell TD
    J Leukoc Biol; 2016 Aug; 100(2):361-9. PubMed ID: 27059843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids.
    Bowman CC; Clements JD
    Infect Immun; 2001 Mar; 69(3):1528-35. PubMed ID: 11179323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit.
    Boyaka PN; Ohmura M; Fujihashi K; Koga T; Yamamoto M; Kweon MN; Takeda Y; Jackson RJ; Kiyono H; Yuki Y; McGhee JR
    J Immunol; 2003 Jan; 170(1):454-62. PubMed ID: 12496431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity correlations of variant forms of the B pentamer of Escherichia coli type II heat-labile enterotoxin LT-IIb with Toll-like receptor 2 binding.
    Cody V; Pace J; Nawar HF; King-Lyons N; Liang S; Connell TD; Hajishengallis G
    Acta Crystallogr D Biol Crystallogr; 2012 Dec; 68(Pt 12):1604-12. PubMed ID: 23151625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational analysis of the role of ADP-ribosylation activity and GM1-binding activity in the adjuvant properties of the Escherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin.
    de Haan L; Feil IK; Verweij WR; Holtrop M; Hol WG; Agsteribbe E; Wilschut J
    Eur J Immunol; 1998 Apr; 28(4):1243-50. PubMed ID: 9565364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct cytokine regulation by cholera toxin and type II heat-labile toxins involves differential regulation of CD40 ligand on CD4(+) T cells.
    Martin M; Metzger DJ; Michalek SM; Connell TD; Russell MW
    Infect Immun; 2001 Jul; 69(7):4486-92. PubMed ID: 11401990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational analysis of the ganglioside-binding activity of the type II Escherichia coli heat-labile enterotoxin LT-IIb.
    Connell TD; Holmes RK
    Mol Microbiol; 1995 Apr; 16(1):21-31. PubMed ID: 7651134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomodulation using bacterial enterotoxins.
    Simmons CP; Ghaem-Magami M; Petrovska L; Lopes L; Chain BM; Williams NA; Dougan G
    Scand J Immunol; 2001 Mar; 53(3):218-26. PubMed ID: 11251877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloning, nucleotide sequence, and hybridization studies of the type IIb heat-labile enterotoxin gene of Escherichia coli.
    Pickett CL; Twiddy EM; Coker C; Holmes RK
    J Bacteriol; 1989 Sep; 171(9):4945-52. PubMed ID: 2670900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The A subunit of type IIb enterotoxin (LT-IIb) suppresses the proinflammatory potential of the B subunit and its ability to recruit and interact with TLR2.
    Liang S; Wang M; Triantafilou K; Triantafilou M; Nawar HF; Russell MW; Connell TD; Hajishengallis G
    J Immunol; 2007 Apr; 178(8):4811-9. PubMed ID: 17404262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G).
    McNeal MM; VanCott JL; Choi AH; Basu M; Flint JA; Stone SC; Clements JD; Ward RL
    J Virol; 2002 Jan; 76(2):560-8. PubMed ID: 11752147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in nontoxic Escherichia coli heat-labile toxin and its derivative adjuvants.
    Ma Y
    Expert Rev Vaccines; 2016 Nov; 15(11):1361-1371. PubMed ID: 27118519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The A subunit of Escherichia coli heat-labile enterotoxin functions as a mucosal adjuvant and promotes IgG2a, IgA, and Th17 responses to vaccine antigens.
    Norton EB; Lawson LB; Mahdi Z; Freytag LC; Clements JD
    Infect Immun; 2012 Jul; 80(7):2426-35. PubMed ID: 22526674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.